These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3040174)

  • 1. The effects of cholecystokinin and cholecystokinin antagonists on synaptic function in the CA1 region of the rat hippocampal slice.
    Jaffe DB; Aitken PG; Nadler JV
    Brain Res; 1987 Jul; 415(1):197-203. PubMed ID: 3040174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin and cholecystokinin antagonists enhance postsynaptic excitability in the dentate gyrus.
    Sinton CM
    Peptides; 1988; 9(5):1049-53. PubMed ID: 3244557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of synaptic transmission in the hippocampus by cholecystokinin (CCK) and its antagonism by a CCK analog (CCK27-33).
    MacVicar BA; Kerrin JP; Davison JS
    Brain Res; 1987 Mar; 406(1-2):130-5. PubMed ID: 3032354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin modulates neurotransmission through the dentate gyrus.
    Sinton CM
    Neurosci Lett; 1988 Dec; 95(1-3):341-6. PubMed ID: 2852324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of moderate changes of extracellular K+ and Ca2+ on synaptic and neural function in the CA1 region of the hippocampal slice.
    Balestrino M; Aitken PG; Somjen GG
    Brain Res; 1986 Jul; 377(2):229-39. PubMed ID: 3015348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
    Sakatani N; Inui A; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin octapeptide increases spontaneous glutamatergic synaptic transmission to neurons of the nucleus tractus solitarius centralis.
    Baptista V; Zheng ZL; Coleman FH; Rogers RC; Travagli RA
    J Neurophysiol; 2005 Oct; 94(4):2763-71. PubMed ID: 16093341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin octapeptide, proglumide, and passive avoidance in rats.
    Deupree D; Hsiao S
    Peptides; 1987; 8(1):25-8. PubMed ID: 3575151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin and an evoked response in the dentate gyrus.
    Sinton CM
    Neuropeptides; 1988 Jul; 12(1):29-34. PubMed ID: 3419558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
    Tokarski K; Bijak M
    Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low glucose concentration on synaptic transmission in the rat hippocampal slice.
    Fan P; O'Regan PA; Szerb JC
    Brain Res Bull; 1988 Nov; 21(5):741-7. PubMed ID: 2851374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus.
    Collingridge GL; Kehl SJ; McLennan H
    J Physiol; 1983 Jan; 334():33-46. PubMed ID: 6306230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsulfated CCK-8 not blocked by proglumide or CR 1409 in the mouse abdominal irritant-induced stretching assay: possible central site of action.
    Ambrose FG; Barbaz BS; Autry WL; Browne RG; Liebman JM
    Peptides; 1989; 10(1):31-4. PubMed ID: 2748423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
    Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cholecystokinin-receptor antagonists on cholecystokinin-stimulated bile flow in dogs.
    Westfall S; Andrus C; Schlarman D; Kaminski DL
    Surgery; 1991 Mar; 109(3 Pt 1):294-300. PubMed ID: 2000561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin octapeptide, proglumide, and conditioned taste avoidance in rats.
    Deupree D; Hsiao S
    Physiol Behav; 1987; 41(2):125-8. PubMed ID: 3685161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.